CA
NZ
UK
AU
IND
US
State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing a beneficial ownership position in Gevo Inc. common stock as of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 2,015,422 shares of GRAIL Inc common stock as of September 30, 2026.
Torsten Rudolf Willi Dehner, SVP GM Fendt/Valtra at AGCO Corp, filed a Form 4 on November 10, 2026, disclosing two open-market sales of AGCO common stock totaling 27,393 shares across November 6 and November 9, 2026.
Xilio Therapeutics, Inc. filed a Form S-8 registration statement with the U.S. Securities and Exchange Commission on November 10, 2026, to register 250,000 additional shares under its Third Amended and Restated 2022 Inducement Stock Incentive Plan.
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 6,254,871 shares of Glacier Bancorp Inc common stock as of September 30, 2026.
Mirum Pharmaceuticals, Inc. filed a Form 8-K on November 10, 2026, announcing that brelovitug met the primary endpoint in the Phase 3 AZURE-4 study evaluating the drug for the treatment of chronic hepatitis delta virus, and highlighting long-term brelovitug data presented at the American …
● The medical services expense ratio improved to 88.5% from 104.0%.
● Third-quarterRevenuerose 55% to $2.185 billion.
● Funds from operations, as adjusted, were $1.54 per share versus $2.22.
● Third-quarterRevenuewas about $1.71 billion, up about 30%.
Please wait processing your request...